Skip to main content

GENERAL COMMENTARY article

Front. Oncol.
Sec. Genitourinary Oncology
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1417921

Commentary: Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis

Provisionally accepted
Tao Wang Tao Wang Xuan Zhang Xuan Zhang Guo-Ming Zhang Guo-Ming Zhang *
  • Shuyang Hospital, Shuyang, China

This article is a commentary on:

  1. Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis

    1. Read original article

The final, formatted version of the article will be published soon.

    Keywords: EZH2, Bladder cancer, diagnosis, ROC, biomarker

    Received: 15 Apr 2024; Accepted: 02 Sep 2024.

    Copyright: © 2024 Wang, Zhang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Guo-Ming Zhang, Shuyang Hospital, Shuyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.